Captivision Inc Ordinary Shares CAPT 深 滬
等待開盤 09-27 09:30:00 美东时间
0.8414
-0.126
-13.04%
華盛通- 最 高0.9801
- 今 開0.9675
- 成交量 31.74万股
- 最 低 0.8206
- 昨 收 0.9676
- 總市值 3083.18万
- 52周最高 2.14
- 市盈率 靜 --
- 換手率 0.00%
- 52周最低 0.3703
- 委 比 15.15%
- 總股本 3664.35万
- 歷史最高 7.919
- 量 比 1.75
- 振 幅 16.48%
- 歷史最低 0.3703
- 每 手 1
- 風險率 1.72%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多Profound Medical rises as TULSA procedure launched at Dallas Medical Center
Shares of Profound Medical (NASDAQ:PROF) traded higher after the company announced that Dallas Medical Center is launching the TULSA procedure, a minimally invasive procedure to treat prostate disease...
09-24 00:58
Capitan Silver Enhances Leadership Team with Strategic Appointments
Capitan Silver ( ($TSE:CAPT) ) has issued an update. Capitan Silver Corp. has a...
09-16 19:49
谷歌前安全负责人募资1300万美元，旨在拦截恶意邮件
随着人工智能（AI）正越来越多地帮助黑客发起大规模邮件攻击，谷歌前安全负责人已联手打造自主 AI 代理，力求在钓鱼邮件、恶意软件及企业邮件入侵威胁触及用户收...
09-10 19:40
Purple Biotech Announced Its Second CAPTN-3 Trispecific Antibody, IM1305, Targeting TROP2 In Development, FDA Investigational New Drug Submission Planned For 2026
IM1305 (capped-CD3xTROP2xNKG2A) contains a masked anti-CD3 arm, as well as an anti-NKG2A arm, and an anti-TROP2 arm. The potent anti-CD3 arm is masked at the periphery with a cleavable cap, designed to be removed
09-03 19:14
12 Industrials Stocks Moving In Thursday's After-Market Session
Gainers Expion360 (NASDAQ:XPON) stock increased by 20.3% to $1.84 during Thurs...
08-22 05:05
Profound Medical预计2025年营收增长70%-75%
美股周五早盘，Profound Medical（PROF）股价下跌6%，该公司预计2025年营收增长70%-75%，主要得益于其TULSA-AI技术和CA...
08-15 22:31
Captivision Inc. Faces Uncertainty After Auditor Resignation
Captivision Inc ( ($CAPT) ) has shared an announcement. On August 1, 2025, Capt...
08-08 06:10
Captivision Accelerates Strategic Transformation Featuring Asset-Light Focus
Captivision Inc. announced a strategic transformation to optimize resources and focus on high-growth LED markets. The company is exploring strategic options for its Korean subsidiary, including divestiture, to transition to an asset-light model. Key growth areas include sports/entertainment LED solutions, commercial applications, and technology innovation. The transformation aims to improve capital efficiency, margins, and agility, positioning Ca...
08-07 21:30
Captivision, Inc. Announces Extension Granted by Nasdaq to Regain Compliance with Periodic Filing Requirement
Captivision Inc. has secured approval from the Nasdaq Hearings Panel to continue listing on the Nasdaq, contingent on meeting certain conditions tied to its efforts to comply with the Periodic Filing Rule. The company is collaborating with its auditor, KPMG, to finalize restated financials and aims to submit its 2024 Annual Report by September 30, 2025. It must provide an audit update by August 29 and demonstrate full compliance by October 15. Wh...
07-29 12:00
Purple Biotech's Chief Executive Officer Gil Efron Issued A Letter To Shareholders Highlighting The Company's Scientific Progress, Operational Execution, And Strategic Milestones During 1H 2025
2025 First Half HighlightsCM24 (α-CEACAM1 monoclonal antibody)Our Phase 2 dataset demonstrated strong objective response rates (ORR) in biomarker-enriched subgroups of second line PDAC patients, as outlined below. These
07-24 19:29
